Circulating glutamate concentration as a biomarker of visceral obesity and associated metabolic alterations

DC FieldValueLanguage
dc.contributor.authorMaltais-Payette, Ina-
dc.contributor.authorBoulet, Marie-Michèle-
dc.contributor.authorPrehn, Cornelia-
dc.contributor.authorAdamski, Jerzy-
dc.contributor.authorTchernof, André-
dc.date.accessioned2020-08-26T17:46:26Z-
dc.date.available2020-08-26T17:46:26Z-
dc.date.issued2018-11-06-
dc.identifier.issn1743-7075fr
dc.identifier.urihttp://hdl.handle.net/20.500.11794/40217-
dc.description.abstractBackground Visceral adipose tissue (VAT) area is a strong predictor of obesity-related cardiometabolic alterations, but its measurement is costly, time consuming and, in some cases, involves radiation exposure. Glutamate, a by-product of branched-chain-amino-acid (BCAA) catabolism, has been shown to be increased in visceral obese individuals. In this follow-up data analysis, we aimed to investigate the ability of plasma glutamate to identify individuals with visceral obesity and concomitant metabolic alterations. Methods Measurements of adiposity, targeted blood metabolomics and cardiometabolic risk factors were performed in 59 healthy middle-aged women. Visceral and subcutaneous adipose tissue areas were measured by computed tomography (CT) whereas body fat and lean mass were assessed by dual-energy x-ray absorptiometry (DEXA). Results The univariate Pearson correlation coefficient between glutamate and VAT area was r = 0.46 (p < 0.001) and it was r = 0.36 (p = 0.006) when adjusted for total body fat mass. Glutamate allowed to identify individuals with VAT areas ≥100 cm2 (ROC_AUC: 0.78, 95% CI: 0.66–0.91) and VAT ≥130 cm2 (ROC_AUC: 0.71, 95% CI: 0.56–0.87). The optimal glutamate concentration threshold determined from the ROC curve (glutamate ≥34.6 μmol/L) had a greater sensitivity than the metabolic syndrome (MetS) and the hypertriglyceridemic waist (HTW) phenotype to identify individuals with VAT ≥100 cm2 (83% for glutamate vs 52% for the MetS and 35% for the HTW). Variance analysis showed that women with a high circulating glutamate level (≥34.6 μmol/L) had an altered metabolic profile, particularly regarding total triglyceride levels and the amount of triglycerides and cholesterol in very-low-density lipoproteins (all p < 0.01). Conclusion Circulating glutamate is strongly associated with VAT area and may represent a potential screening tool for visceral obesity and alterations of the metabolic profile.fr
dc.languageengfr
dc.publisherBioMed Centralfr
dc.subjectGlutamatefr
dc.subjectMetabolomicsfr
dc.subjectBranched-chain amino acidsfr
dc.subjectVisceral obesityfr
dc.subjectWaist circumferencefr
dc.titleCirculating glutamate concentration as a biomarker of visceral obesity and associated metabolic alterationsfr
dc.title.alternativeGlutamate concentrations and visceral obesity-related cardiometabolic riskfr
dc.typeCOAR1_1::Texte::Périodique::Revue::Contribution à un journal::Article::Article de recherchefr
dcterms.bibliographicCitationNutrition and metabolism, Vol. 15 (78) 2018fr
dc.identifier.doi10.1186/s12986-018-0316-5fr
dc.identifier.pubmed30450120fr
dc.subject.rvmAcide glutamiquefr
dc.subject.rvmMarqueurs biologiquesfr
dc.subject.rvmObésité androïdefr
dc.subject.rvmTour de taillefr
dc.subject.rvmMétabolomiquefr
rioxxterms.versionAccepted Manuscriptfr
rioxxterms.version_of_recordhttps://doi.org/10.1186/s12986-018-0316-5fr
rioxxterms.project.funder_nameCanadian Institutes of Health Researchfr
bul.rights.periodeEmbargo0 moisfr
bul.rights.addendumDroits de diffusion transférés à l'éditeur.fr
Collection:Articles publiés dans des revues avec comité de lecture

Files in this item:
Description SizeFormat 
NUAM-D-18-00173 - Corpus w fig.pdf210.96 kBAdobe PDFThumbnail
View/Open
All documents in CorpusUL are protected by Copyright Act of Canada.